Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This trial was terminated prematurely on April 2, 2012, due to the inability to recruit the planned number of subjects. The decision to terminate the trial was not based on any safety or efficacy concerns.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A physician-confirmed diagnosis of either pDPN or FM, but not both.
Initiation of a medication for pDPN or FM is clinically indicated, either as monotherapy or in combination with other treatments, as determined by the treating physician, and agreed to by the patient.
No prior pregabalin use or pregabalin PA requests.
You may not be if
Age \< 18 years at time of study enrollment.
Females or are partners of males currently pregnant/lactating or intending to become pregnant in the next 6 months
Physician-confirmed diagnosis of both pDPN and FM.
Clareo Health | Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
